Clinical Trial Update: A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study [Phase 2]

View source ↗

Summary

Phase 2 trial update of vismodegib in patients previously treated with vismodegib, with the study status completed and results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Colorectal Cancer
• Ovarian Cancer

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Ovarian Cancer, Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-01-07